Press Releases
Epic Sciences Publication Validates Unbiased Detection of Circulating Tumor Cells (CTCs) from a Liquid Biopsy
SAN DIEGO, August 11, 2015 /PRNewswire/ -- Epic Sciences announced today the publication of its research in the Journal of Circulating Biomarkers validating the company’s no cell left behind™ platform. The data published demonstrate reproducible and…
Epic Sciences Appoints Dr. Greg Critchfield to Board of Directors
SAN DIEGO, July 13, 2015 -- Epic Sciences, Inc. ("Epic Sciences"), a private biotech company that develops diagnostics to personalize the treatment and management of cancer, announced today the appointment of Gregory C. Critchfield, M.D. to Epic Sciences'…
Epic Sciences Expands Partnership with LabCorp to Provide Circulating Tumor Cell Analysis And Support Oncology Clinical Trials in Asia
SAN DIEGO and SINGAPORE, July 7, 2015 -- Epic Sciences (Epic) announced today an agreement with Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) to provide circulating tumor cell (CTC) technology and support oncology clinical trials in…
Epic Sciences Expands Silicon Valley Bank Credit Facility
SAN DIEGO, June 1, 2015 — Epic Sciences, Inc., a private diagnostics company that designs and develops products and offerings to personalize and advance the treatment and management of cancer, announced today that it has expanded the available credit…
Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-Patient Heterogeneity
SAN DIEGO, May 29, 2015 -- Epic Sciences announced today that the company will present single cell sequencing data, from metastatic castrate resistant prostate cancer patients, at the 2015 annual meeting of the American Society for Clinical Oncology. This…
Epic Sciences to Present at UBS Global Healthcare Conference
SAN DIEGO, May 14, 2015 -- Epic Sciences, Inc. ("Epic"), a private biotech company that designs and develops diagnostics to personalize and advance the treatment and management of cancer, announced today that Michael Rodriguez, chief financial officer,…
Epic Sciences Demonstrates Single Cell Genetic Analysis for Circulating Tumor Cells
SAN DIEGO, April 16, 2015 /PRNewswire/ -- Epic Sciences announced today that its no cell left behind™technology has successfully integrated single cell isolation and downstream genetic analysis of circulating tumor cells (CTCs) to the platform's…
Epic Sciences and The Prostate Cancer Clinical Trials Consortium Collaborate to Advance Therapeutic Development
SAN DIEGO – March 9, 2015 – Epic Sciences and The Prostate Cancer Clinical Trials Consortium (PCCTC), the leading consortium for Phase 1/2 and Phase 2 clinical trials in prostate cancer, announced today they have entered into a collaboration to apply…
Epic Sciences to Present at 35th Annual Cowen and Company Health Care Conference
SAN DIEGO, Feb. 26, 2015 /PRNewswire/ — Epic Sciences announced today that President and CEO Murali Prahalad, Ph.D. will present at the 35th Annual Cowen and Company Health Care Conference on Wednesday, March 4, 2015 at 10:00 a.m. EST in the MIT Room, 3rd…
Epic Sciences Appoints Chris Bernard as Chief Commercial Officer
SAN DIEGO, Feb. 25, 2015 /PRNewswire/ -- Epic Sciences announced today the appointment of Chris Bernard as chief commercial officer. Mr. Bernard has more than 20 years of experience as a senior executive and company officer leading sales and marketing…